Advanced Nuclear Medicine & Theranostics
For Precision-Guided Cancer Care.
Disease-specific imaging and radiopharmaceutical therapies built around molecular targets, from PSMA and FAPI to somatostatin receptors.
Sarvodaya Hospital, Faridabad | Delhi NCR
Dr. Swagat Dash is a renowned nuclear medicine physician in India with over 15 years of experience. He specializes in PET-CT procedures, radionuclide therapy in India, and nuclear thyroidology. Dr. Dash is known for his expertise in diagnosing and treating various medical conditions, including cancer, heart diseases, and brain disorders.
Dr. Vindhya Malasani is an attending consultant in Nuclear Medicine, specializing in the fields of Nuclear Medicine and Molecular Theranostics in Delhi NCR, India. In her role, she likely focuses on diagnosing and treating various conditions using nuclear imaging techniques and therapeutic applications of radiopharmaceuticals.
PET Scans: Accurate imaging for early detection and effective diagnosis
PET Scans: Accurate imaging for early detection and effective diagnosis
Nuclear Therapies: Advanced treatments targeting specific conditions with precision.
Nuclear Therapies: Advanced treatments targeting specific conditions with precision.
- Molecular Imaging: Explore disease-specific PET scans using targeted molecular tracers.
- Advanced Tracers: PSMA, FAPI, FDG and other tracers for specific clinical needs.
- Clinical Insight: Imaging that helps assess disease biology and treatment options.
- Specialist Guidance: PET imaging selected according to your clinical condition.
- Patient Support: Clear preparation and scan guidance throughout your visit.
- Targeted Therapy: Radiopharmaceuticals designed to reach specific molecular targets.
- Theranostics: Connect molecular imaging with targeted treatment approaches.
- Radionuclide Therapy: Options including PSMA therapy and PRRT for selected patients.
- Specialist Evaluation: Treatment suitability assessed according to individual clinical factors.
- Ongoing Guidance: Clear instructions before, during and after radionuclide therapy.
0
%+
0
+
0
+
Theranostics combines molecular imaging with targeted therapy, using a scan to confirm a molecular target before a matching treatment is considered.
A targeted radionuclide therapy for eligible patients with PSMA-expressing prostate cancer, delivered under specialist supervision.
Eligibility depends on PSMA expression on imaging, prior treatment history and overall clinical status, assessed case by case.
Services may include PET-CT imaging, PSMA PET, FAPI PET, FDG PET, DOTATATE PET, PRRT, Lu-177 PSMA and other targeted radionuclide therapies, depending on clinical indication and availability.
PRRT, or peptide receptor radionuclide therapy, is a targeted treatment for selected neuroendocrine tumours. It uses a radiolabelled peptide to deliver radiation to cells expressing specific receptors, such as somatostatin receptors.
A PET scan uses a small amount of radioactive material to visualize metabolic activity in the body, helping detect cancer and other diseases.
Yes, PET scans are considered safe; the radiation exposure is minimal and comparable to other imaging tests.
You will receive a radioactive tracer, wait for it to circulate, and then lie down in a scanner for about 20-30 minutes while images are taken.
Preparation varies by scan type and may include fasting or medication adjustments; instructions are provided ahead of your appointment.
PET-CT scans using different molecular tracers are available at specialised nuclear medicine centres across Delhi NCR. The appropriate scan depends on the disease being evaluated and the clinical question.
Contact for appointments for Scans and Therapies.
+91-9650057298
drswagatofficial@gmail.com
Sarvodaya Hospital,
Sector 8, Faridabad, Haryana, India
Sector 8, Faridabad, Haryana, India